⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ILMN

Illumina, Inc.

Healthcare · Diagnostics & Research

205.00USD

-6.0600 (-2.87%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 205.00
P/E37.5
Dvd Ind Yld—
P/B10.91
P/S6.9
Curr EV/T12M EBITDA28.9
Mkt Cap (USD)31.0B
Curr EV (USD)32.3B
2)

Per Share Data

EPS T12M5.36
DPS—
Bk Val Per Sh18.80
Rev/Sh29.37
Cash/Sh7.74
Curr Shares Out151.0M
FCF/Sh6.08
3)

Cash Flow Analysis

P/CF28.3
Curr P/FCF33.2
CF/NI1.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales24.4%
Eff Interest Rate12.1%
4)

Growth Potential

Dil EPS 1Y Gr170.9%
Cap 1Y Gr14.7%
BPS 1Y Gr17.0%
R&D To Sales21.4%
Retention Rate100.0%
Rev 1Y Gr-0.7%
FCF 1Y Gr31.3%
Assets 1Y Gr5.4%
5)

Profitability

EBITDA1.1B
EBIT0.9B
Operating Margin19.6%
Pretax Margin22.6%
Net Margin18.4%
ROA13.0%
ROE32.4%
ROC17.9%
Asset Turnover0.71
6)

Structure

Current Ratio1.80
Quick Ratio1.25
Debt/Assets17.5%
Debt/Com Eq41.1%
Net Debt/EBITDA0.02
Tot Debt/Capital29.1%
Gross Margin66.4%
EBIT/Int Exp8.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.